Stories by Nature Biotechnology

Companies attract venture funding for redesigned psychedelic drugs

The aviation industry is getting ready to embrace fuel produced by fermentation

A bioreactor-made material is being marketed as an animal-friendly leather alternative that also aims to help save the planet

Novel types of jabs could enhance T-cell immunity or protect against emerging strains

Start-ups bet that carefully controlled cell reprogramming may lead to age reversal, but hurdles remain

SARS-CoV-2 adds impetus to the race for broad-spectrum countermeasures against future global infectious scourges

The first commercial food product to use the CRISPR gene-editing technique increases levels of GABA in tomatoes

Cell-based fish taste the same as their wild and farmed counterparts. But will it ever make economic sense to produce this kind of protein?

A wave of funding focuses on antiviral nanomaterials as COVID countermeasures

Ginsberg collaborates with synthetic biologists to create eau de Leucadendron and her latest: artwork for insects

Club-goers in the island city-state take first bites of slaughter-free chicken nuggets grown in bioreactors

Next-generation COVID-19 vaccines will not only tackle different versions of the virus but will provide solutions across the world at a fraction of the cost